TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study

BACKGROUND: TAS-102 is an oral monotherapy, combining trifluridine and tipiracil hydrochloride, indicated for the treatment of pretreated metastatic colorectal cancer (mCRC). The aim of this real-life study is to evaluate the efficacy and safety of TAS-102 in heavily pretreated elderly patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicero, Giuseppe, Addeo, Raffaele, De Luca, Rossella, Lo Re, Giuseppe, Gulotta, Leonardo, Marchesa, Pierenrico, Gulotta, Gaspare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505119/
https://www.ncbi.nlm.nih.gov/pubmed/32994802
http://dx.doi.org/10.7573/dic.2020-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505119/
https://www.ncbi.nlm.nih.gov/pubmed/32994802
http://dx.doi.org/10.7573/dic.2020-6-3

Ejemplares similares